Our website uses cookies to ensure you get the best experience with the most relevant info provided

Cardiolyse Successfully Finished the Stage 2 Audit for ISO 13485 and CE as a Medical Software Certification

An amazing end of the intense week and the challenging last months overall.

Cardiolyse has successfully finished the stage 2 audit for ISO 13485 and CE as a medical software certification.

CE is a certification mark that indicates conformity with health, safety, and environmental protection standards for products sold within the European Economic Area.

CE is essential to fully enter the EU digital healthcare market and proceed with commercial partnerships there.

The independent auditors from TUV Rheinland have reviewed our software as well as all the technical documentation needed to pass the CE marking process.

Cardiolyse’s ECG analyzing algorithms are now going to be reviewed by the clinical experts, that is the last stage in decision-making process about issuing the certificate.

Congratulations to all the amazing team!

Great things take time, but now we are one step closer to our next exciting achievement.

Back to blog

Related posts

Cardiolyse Cardiac Analytics solution in COVID-19 Disruptive circumstances

Cardiolyse presenting its solution at Arab Health 2020

Cardiolyse pitched at corporate challenges at HTH Styria Pitch & Partner event

CE certificate for class IIa software medical device issued

Cardiolyse was issued with a US patent for its proprietary Method of ECG evaluation

Read more

Let’s work together
on heart health improvement